BioCentury | Feb 21, 2011
Clinical News

Sareum preclinical data

In an animal model of AML, no detectable cancer was found in 2 of 10 animals treated with Sareum's inhibitor of aurora kinases and FMS-like tyrosine kinase 3 (FLT3; CD135 ) at 6 weeks post-treatment. In...
Items per page:
1 - 1 of 1